REAL-WORLD EXPERIENCE OF GLECAPREVIR/PIBRENTASVIR TREATMENT IN JAPANESE ADOLESCENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY

被引：0

作者：

Mizuochi, Tatsuki ^{[1
]}

Iwama, Itaru ^{[2
]}

Inui, Ayano ^{[3
]}

Ito, Yoshinori ^{[4
]}

Takaki, Yugo ^{[5
]}

Mushiake, Sotaro ^{[6
]}

Tokuhara, Daisuke ^{[7
]}

Ishige, Takashi ^{[8
]}

Ito, Koichi ^{[9
]}

Murakami, Jun ^{[10
]}

Hishiki, Haruka ^{[11
]}

Mikami, Hitoshi ^{[12
]}

Bessho, Kazuhiko ^{[13
]}

Kato, Ken ^{[1
]}

Yasuda, Ryosuke ^{[1
]}

Yamashita, Yushiro ^{[1
]}

Tanaka, Yasuhito ^{[14
,15
,16
]}

Tajiri, Hitoshi ^{[17
]}

机构：

[1] Kurume Univ, Pediat & Child Hlth, Sch Med, Kurume, Fukuoka, Japan

[2] Saitama Childrens Med Ctr, Gastroenterol & Hepatol, Saitama, Japan

[3] Saiseikai Yokohamashi Tobu Hosp, Pediat Hepatol & Gastroenterol, Yokohama, Kanagawa, Japan

[4] Nagoya Univ, Pediat, Grad Sch Med, Nagoya, Aichi, Japan

[5] Japanese Red Cross Kumamoto Hosp, Pediat, Kumamoto, Japan

[6] Kindai Univ, Pediat, Nara Hosp, Higashiosaka, Osaka, Japan

[7] Osaka City Univ, Pediat, Grad Sch Med, Osaka, Japan

[8] Gunma Univ, Pediat, Grad Sch Med, Gunma, Japan

[9] Nagoya City Univ, Grad Sch Med Sci, Pediat & Neonatol, Nagoya, Aichi, Japan

[10] Tottori Univ, Pediat & Perinatol, Fac Med, Tottori, Japan

[11] Chiba Univ Hosp, Pediat, Chiba, Japan

[12] Iwate Prefectural Cent Hosp, Pediat, Morioka, Iwate, Japan

[13] Osaka Univ, Grad Sch Med, Pediat, Osaka, Japan

[14] Kumamoto Univ, Dept Gastroenterol & Hepatol, Fac Life Sci, Kumamoto, Japan

[15] Nagoya City Univ, Dept Virol, Grad Sch Med Sci, Nagoya, Aichi, Japan

[16] Nagoya City Univ, Liver Unit, Grad Sch Med Sci, Nagoya, Aichi, Japan

[17] Kindai Univ, Pediat, Fac Med, Higashihiroshima, Japan

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

4803

引用

页码：S1524 / S1525

页数：2

共 50 条

[21] The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study
Akito Nozaki
Masanori Atsukawa
Chisa Kondo
Hidenori Toyoda
Makoto Chuma
Makoto Nakamuta
Haruki Uojima
Koichi Takaguchi
Hiroki Ikeda
Tsunamasa Watanabe
Shintaro Ogawa
Norio Itokawa
Taeang Arai
Atsushi Hiraoka
Toru Asano
Shinichi Fujioka
Tadashi Ikegami
Toshihide Shima
Chikara Ogawa
Takehiro Akahane
Noritomo Shimada
Shinya Fukunishi
Hiroshi Abe
Akihito Tsubota
Takuya Genda
Hironao Okubo
Shigeru Mikami
Asahiro Morishita
Akio Moriya
Joji Tani
Yoshihiko Tachi
Naoki Hotta
Toru Ishikawa
Takeshi Okanoue
Yasuhito Tanaka
Takashi Kumada
Katsuhiko Iwakiri
Shin Maeda
Hepatology International, 2020, 14 : 225 - 238
[22] Real-World Data on the Use of Glecaprevir/Pibrentasvir in the Treatment of Hepatitis C: Is Shorter Treatment Possible?
Tuzun, Ahmet Yekta
Mermutluoglu, Cigdem
Celen, Mustafa Kemal
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2024, 30 (02): : 36 - 40
[23] REAL-WORLD EXPERIENCE OF 12-WEEK DAA REGIMEN OF GLECAPREVIR AND PIBRENTASVIR IN JAPANESE PATIENTS WITH CHRONIC HCV INFECTION
Yasuda, Satoshi
Toyoda, Hidenori
Iio, Etsuko
Akahane, Takehiro
Fujioka, Shinichi
Kunihiko, Tsuji
Shimada, Noritomo
Ishikawa, Toru
Tachi, Yoshihiko
Hotta, Naoki
Tanaka, Yasuhito
Kumada, Takashi
HEPATOLOGY, 2019, 70 : 928A - 928A
[24] Real-world data on safety and effectiveness of glecaprevir/pibrentasvir for the treatment of patients with chronic hepatitis C virus infection: updated data from the German Hepatitis C-Registry
Cornberg, M.
Naumann, U.
Stoehr, A.
Sick, C.
Teuber, G.
Schiffelholz, W.
Mauss, S.
Lohmann, K.
Kleine, H.
Pangerl, A.
Mueller, T.
JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 197 - 198
[25] The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study
Nozaki, Akito
Atsukawa, Masanori
Kondo, Chisa
Toyoda, Hidenori
Chuma, Makoto
Nakamuta, Makoto
Uojima, Haruki
Takaguchi, Koichi
Ikeda, Hiroki
Watanabe, Tsunamasa
Ogawa, Shintaro
Itokawa, Norio
Arai, Taeang
Hiraoka, Atsushi
Asano, Toru
Fujioka, Shinichi
Ikegami, Tadashi
Shima, Toshihide
Ogawa, Chikara
Akahane, Takehiro
Shimada, Noritomo
Fukunishi, Shinya
Abe, Hiroshi
Tsubota, Akihito
Genda, Takuya
Okubo, Hironao
Mikami, Shigeru
Morishita, Asahiro
Moriya, Akio
Tani, Joji
Tachi, Yoshihiko
Hotta, Naoki
Ishikawa, Toru
Okanoue, Takeshi
Tanaka, Yasuhito
Kumada, Takashi
Iwakiri, Katsuhiko
Maeda, Shin
HEPATOLOGY INTERNATIONAL, 2020, 14 (02) : 225 - 238
[26] First real-world data on safety and effectiveness of glecaprevir/pibrentasvir for the treatment of patients with chronic hepatitis C virus infection: Data from the German Hepatitis C-Registry
Berg, T.
Naumann, U.
Stoehr, A.
Sick, C.
Teuber, G.
Schiffelholz, W.
Mauss, S.
Hettinger, J.
Kleine, H.
Pangerl, A.
Niederau, C.
JOURNAL OF HEPATOLOGY, 2018, 68 : S37 - S37
[27] Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases
Sugiura, Ayumi
Joshita, Satoru
Yamashita, Yuki
Yamazaki, Tomoo
Fujimori, Naoyuki
Kimura, Takefumi
Matsumoto, Akihiro
Wada, Shuichi
Mori, Hiromitsu
Shibata, Soichiro
Yoshizawa, Kaname
Morita, Susumu
Furuta, Kiyoshi
Kamijo, Atsushi
Iijima, Akihiro
Kako, Satoko
Maruyama, Atsushi
Kobayashi, Masakazu
Komatsu, Michiharu
Matsumura, Makiko
Miyabayashi, Chiharu
Ichijo, Tetsuya
Takeuchi, Aki
Koike, Yuriko
Gibo, Yukio
Tsukadaira, Toshihisa
Inada, Hiroyuki
Nakano, Yoshiyuki
Usuda, Seiichi
Kiyosawa, Kendo
Tanaka, Eiji
Umemura, Takeji
BIOMEDICINES, 2020, 8 (04)
[28] Prospective multicenter study of glecaprevir plus pibrentasvir combination therapy for patients with chronic hepatitis C
Tamori, Akihiro
Iwasa, Motoo
Inoue, Kazuaki
Kagawa, Tatehiro
Takaguchi, Koichi
Minami, Masahito
Iwasaki, Yoshiaki
Nouso, Kazuhiro
Hoang, Hai
Enomoto, Masaru
Kawada, Norifumi
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E242 - E243
[29] Real World Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Infection: A Meta-Analysis
Cornberg, Markus
Negro, Francesco
Lampertico, Pietro
Turnes, Juan
Curry, Michael P.
Brown, Ashley
Wedemeyer, Heiner
Carrion, Jose A.
Wick, Nicole
Pangerl, Andreas
Larsen, Lois
Yu, Yao
Persico, Marcello
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S600 - S600
[30] Real-world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in Taiwan
Chiu, Wen-Nan
Hung, Chao-Hung
Lu, Sheng-Nan
Chen, Mei-Yen
Tung, Shui-Yi
Wei, Kuo-Liang
Lu, Chung-Kuang
Chen, Chien-Hung
Hu, Tsung-Hui
Hu, Jin-Hung
Chen, Wei-Ming
Chang, Te-Sheng
JOURNAL OF VIRAL HEPATITIS, 2020, 27 (09) : 866 - 872

← 1 2 3 4 5 →